samedan logo

 
 
spacer
home > pmps > summer 2017 > heating up
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Heating Up

One cannot complain that cold chain for the pharmaceutical and biotechnology industries is lacking challenges shipping products globally by airplanes or ocean freighters, for instance, is a hot discussion topic. This obstacle is not new for products and vaccines shipped in the 2-8C range, but for other expanses, like 15-25C, it has a considerable impact.

Almost 50% of temperature excursions take place on the tarmac of an airport; thus, a compliant shipment is important. The only way to maintain product quality is to keep it in prescribed conditions until the moment of use. No patient can benefit from an expired treatment or an inaccurate blood sugar level measurement because the strips were not kept in the right conditions. Even worse, products could become harmful instead of helpful.

From a cost perspective, as well as a qualitative one, the use of ocean freight is transcending that of air transport. Ocean shipping is not only considered for low-value products, but also for high-value ones, such as vaccines.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer
Martin Gouda is a Partner of Supply Chain Strategies at Buck Consultants International and has over 30 years of experience in international supply chain optimisation. He has worked in various roles at the strategic and tactical level in management and consultancy. Martin worked for a global 3PL for almost 10 years in various business development positions. In this period, he was responsible for breakthrough and step change projects with pharma companies. In the last three years, he was leading the healthcare sector on a global level. Martin is co-founder and board member of the Healthcare Logistics Forum. 
spacer
Martin Gouda
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis

The rapid spread of the newly emerging SARS-CoV-2 virus variant B.1.1.7 in Great Britain and other countries shows changes in the genome of the SARS-CoV-2 virus can lead to new biological properties.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement